Showing 6 of 6 recruiting trials for “Myelodysplastic neoplasm with increased blasts”
A Phase Ib Study of Rezatapopt in Combination With Azacitidine in Patients With TP53Y220C Mutant Myeloid Malignancies (Acute Myeloid Leukemia or Myelodysplastic Syndrome)
Preemptive CIML NK Cell Therapy After Hematopoietic Stem Cell Transplantation
Repurposing Metformin As a Leukemia-preventive Drug in CCUS and LR-MDS
👨⚕️ Kirsten Grønbæk, Professor, MD, Rigshospitalet, Denmark📍 1 site📅 Started Dec 2021View details ↗
A Phase Ib Study of APG-115 Single Agent or in Combination With Azacitidine or Cytarabine in Patients With AML and MDS.
👨⚕️ Jianxiang Wang, M.D., Blood Diseases Hospital Chinese Academy of Medical Sciences📍 14 sites📅 Started Jul 2020View details ↗
Ivosidenib and Venetoclax With or Without Azacitidine in Treating Patients With IDH1 Mutated Hematologic Malignancies
Allogeneic Hematopoietic Stem Cell Transplant for GATA2 Mutations
👨⚕️ Danielle E Pregent-Arnold, M.D., National Cancer Institute (NCI)📍 1 site📅 Started Jul 2013View details ↗
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →